Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Genetic risk score based on obesity-related genes and progression in weight loss after bariatric surgery, a 60-month follow-up study

  • Mas-Bermejo, Patricia|||0000-0003-4789-9650
  • Azcona-Granada, Natalia
  • Peña, Elionora
  • Lecube, Albert|||0000-0001-9684-0183
  • Ciudin, Andreea|||0000-0001-5622-0203
  • Simó Canonge, Rafael|||0000-0003-0475-3096
  • Luna, Alexis|||0000-0003-2351-5819
  • Rigla Cros, Mercedes|||0000-0002-6691-4871
  • Arenas Solà, Concepción|||0000-0002-6489-4934
  • Caixàs i Pedragós, Assumpta|||0000-0001-8472-9189
  • Rosa de la Cruz, Araceli|||0000-0001-6935-3785
Background: Obesity is a polygenic multifactorial disease. Recent genome-wide association studies have identified several common loci associated with obesity-related phenotypes. Bariatric surgery (BS) is the most effective long-term treatment for patients with severe obesity. The huge variability in BS outcomes between patients suggests a moderating effect of several factors, including the genetic architecture of the patients. Objective: To examine the role of a genetic risk score (GRS) based on 7 polymorphisms in 5 obesity-candidate genes (FTO, MC4R, SIRT1, LEP, and LEPR) on weight loss after BS. Setting: University hospital in Spain. Methods: We evaluated a cohort of 104 patients with severe obesity submitted to BS (Roux-en-Y gastric bypass or sleeve gastrectomy) followed up for >60 months (lost to follow-up, 19.23%). A GRS was calculated for each patient, considering the number of carried risk alleles for the analyzed genes. During the postoperative period, the percentage of excess weight loss total weight loss and changes in body mass index were evaluated. Generalized estimating equation models were used for the prospective analysis of the variation of these variables in relation to the GRS. Results: The longitudinal model showed a significant effect of the GRS on the percentage of excess weight loss (P = 1.5 × 10-5), percentage of total weight loss (P = 3.1 × 10-8), and change in body mass index (P = 7.8 × 10-16) over time. Individuals with a low GRS seemed to experience better outcomes at 24 and 60 months after surgery than those with a higher GRS. Conclusion: The use of the GRS in considering the polygenic nature of obesity seems to be a useful tool to better understand the outcome of patients with obesity after BS.
Repisalud
Publicación Artículo científico (JournalArticle)

Shoc2/Sur8 Protein Regulates Neurite Outgrowth

  • Leon-Espinosa, Gonzalo
  • Sanchez-Ruiloba, Lucia
  • Perez-Rodriguez, Andrea
  • Gragera, Teresa
  • Martinez, Natalia
  • Hernandez, Silvia
  • Anta-Felez, Berta
  • Calero, Olga
  • Garcia-Dominguez, Carlota A
  • Dura, Lara M
  • Peña-Jimenez, Daniel
  • Castro, Judith
  • Zarich-Dimitrievich, Natasha
  • Sánchez-Gómez, Pilar
  • Calero, Miguel
  • Iglesias, Teresa
  • Oliva-Martinez, Jose Luis
  • Rojas-Cabañeros, Jose Maria
The Shoc2 protein has been implicated in the positive regulation of the Ras-ERK pathway by increasing the functional binding interaction between Ras and Raf, leading to increased ERK activity. Here we found that Shoc2 overexpression induced sustained ERK phosphorylation, notably in the case of EGF stimulation, and Shoc2 knockdown inhibited ERK activation. We demonstrate that ectopic overexpression of human Shoc2 in PC12 cells significantly promotes neurite extension in the presence of EGF, a stimulus that induces proliferation rather than differentiation in these cells. Finally, Shoc2 depletion reduces both NGF-induced neurite outgrowth and ERK activation in PC12 cells. Our data indicate that Shoc2 is essential to modulate the Ras-ERK signaling outcome in cell differentiation processes involved in neurite outgrowth.
Repisalud
Publicación Artículo científico (JournalArticle)

The CSN3 subunit of the COP9 signalosome interacts with the HD region of Sos1 regulating stability of this GEF protein

  • Zarich-Dimitrievich, Natasha
  • Anta, Begoña
  • Fernández-Medarde, Alberto
  • Ballester, Alicia
  • de Lucas, Maria Pilar
  • Camara, Ana Belen
  • Anta-Felez, Berta
  • Oliva-Martinez, Jose Luis
  • Rojas-Cabañeros, Jose Maria
  • Santos, Eugenio
Sos1 is an universal, widely expressed Ras guanine nucleotide-exchange factor (RasGEF) in eukaryotic cells. Its N-terminal HD motif is known to be involved in allosteric regulation of Sos1 GEF activity through intramolecular interaction with the neighboring PH domain. Here, we searched for other cellular proteins also able to interact productively with the Sos1 HD domain. Using a yeast two-hybrid system, we identified the interaction between the Sos1 HD region and CSN3, the third component of the COP9 signalosome, a conserved, multi-subunit protein complex that functions in the ubiquitin-proteasome pathway to control degradation of many cellular proteins. The interaction of CSN3 with the HD of Sos1 was confirmed in vitro by GST pull-down assays using truncated mutants and reproduced in vivo by co-immunoprecipitation with the endogenous, full-length cellular Sos1 protein. In vitro kinase assays showed that PKD, a COP9 signalosome-associated-kinase, is able to phosphorylate Sos1. The intracellular levels of Sos1 protein were clearly diminished following CSN3 or PKD knockdown. A sizable fraction of the endogenous Sos1 protein was found ubiquitinated in different mammalian cell types. A significant reduction of RasGTP formation upon growth factor stimulation was also observed in CSN3-silenced as compared with control cells. Our data suggest that the interaction of Sos1 with the COP9 signalosome and PKD plays a significant role in maintenance of cellular Sos1 protein stability and homeostasis under physiological conditions and raises the possibility of considering the CSN/PKD complex as a potential target for design of novel therapeutic drugs.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Optimized single-point left ventricular pacing leads to improved resynchronization compared with multipoint pacing

  • San Antonio, Rodolfo
  • Guasch, Eduard
  • González-Ascaso, Ana
  • Jiménez-Arjona, Rafael
  • Pujol-López, Margarida
  • Doltra, Adelina
  • Alarcón, Francisco
  • Garre, Paz
  • Liberos Mascarell, Alejandro
  • Trotta, Omar
  • Quinto, Levio
  • Borras, Roger
  • Arbelo, Elena
  • Roca-Luque, Ivo
  • Atienza, Felipe
  • Brugada, Josep
  • Fernandez-Aviles, Francisco
  • Sitges, Marta
  • Tolosana, José María
  • Mont, Lluis
  • Andreu M. Climent|||0000-0002-7260-8811
  • Guillem Sánchez, María Salud|||0000-0001-5660-3693
[EN] Background Multipoint pacing (MPP) in cardiac resynchronization therapy (CRT) activates the left ventricle from two locations, thereby shortening the QRS duration and enabling better resynchronization; however, compared with conventional CRT, MPP reduces battery longevity. On the other hand, electrocardiogram-based optimization using the fusion-optimized intervals (FOI) method achieves more significant reverse remodeling than nominal CRT programming. Our study aimed to determine whether MPP could attain better resynchronization than single-point pacing (SPP) optimized by FOI. Methods This prospective study included 32 consecutive patients who successfully received CRT devices with MPP capabilities. After implantation, the QRS duration was measured during intrinsic rhythm and with three pacing configurations: MPP, SPP-FOI, and MPP-FOI. In 14 patients, biventricular activation times (by electrocardiographic imaging, ECGI) were obtained during intrinsic rhythm and for each pacing configuration to validate the findings. Device battery longevity was estimated at the 45-day follow-up. Results The SPP-FOI method achieved greater QRS shortening than MPP (-56 +/- 16 vs. -42 +/- 17 ms, p < .001). Adding MPP to the best FOI programming did not result in further shortening (MPP-FOI: -58 +/- 14 ms, p = .69). Although biventricular activation times did not differ significantly among the three pacing configurations, only the two FOI configurations achieved significant shortening compared with intrinsic rhythm. The estimated battery longevity was longer with SPP than with MPP (8.1 +/- 2.3 vs. 6.3 +/- 2.0 years, p = .03). Conclusions SPP optimized by FOI resulted in better resynchronization and longer battery duration than MPP., Centro de Investigacion Biomedica en Red Enfermedades Cardiovasculares, Grant/Award Number: CB16/11/00354; Instituto de Salud Carlos III, Grant/Award Numbers: DTS16/0160, PI16/00435, PI16/00703, PI17/01059, PI17/01106; Sociedad Espanola de Cardiologia, Grant/Award Numbers: 2018, SEC_ESTIM_01; Agencia deGestio d'Ajuts Universitaris i de Recerca, Grant/AwardNumber: 2017_SGR_1548; Fundacio laMarato de TV3, Grant/Award Number: 20152730; Horizon 2020 Framework Programme, Grant/Award Number: 633196 - CATCH MEproject; European Regional Development Fund, Grant/Award Number: EITHealth 19600 AFFINE
eBiltegia. Repositorio Institucional de Mondragon Unibertsitatea
Publicación Artículo científico (JournalArticle)

Impact and notched strength of multiaxially reinforced out of die UV cured pultruded profiles

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis

  • Bouchez, Valérie
  • Landier, Annie
  • Armatys, Nathalie
  • Guillot, Sophie
  • Moreno-Mingorance, Albert
  • Mir-Cros, Alba
  • Martin Gomez, M. Teresa
  • González-López, Juan José
Bordetella parapertussis; Phylogenetic diversity; Vaccine driven evolution, Bordetella parapertussis; Diversidad filogenética; Evolución impulsada por vacunas, Bordetella parapertussis; Diversitat filogenètica; Evolució impulsada per vacunes, Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping cough (pertussis) and shares vaccine antigens with Bordetella pertussis (Bp); both pathogens are phylogenetically related and ecological competitors. Bp vaccine antigen-coding genes have accumulated variation, including pertactin (PRN) disruptions, after the introduction of acellular vaccines in the 1990s. We aimed to evaluate evolutionary parallelisms in Bpp, even though pertussis vaccines were designed against Bp. We sequenced 242 Bpp isolates collected in France, the USA and Spain between 1937 and 2019, spanning pre-vaccine and two vaccines eras. We investigated the temporal evolution of Bpp sublineages using a Bayesian approach based on whole-genome SNPs and performed comparative genomic analyses focusing on antigen and virulence gene loci. The most recent common ancestor of all sequenced Bpp isolates was estimated around the year 1877, making it one of the youngest human pathogens, and the Bpp evolutionary rate we estimated (2.12×10−7 substitutions per site per year) was remarkably similar to the one previously reported for Bp (2.24×10−7). PRN antigen deficiency in Bpp was driven by 18 disruptive mutations, including deletion prn:ΔG-1895 estimated to have occurred around 1998 and observed in 73.8 % (149/202) of post-2007 Bpp isolates. In addition, we detected two early (year ~1900) mutations in the bvgA-fhaB intergenic region, which controls multiple virulence factors including the filamentous haemagglutinin antigen. Gene clusters for pertussis toxin and fimbriae showed a surprising lack of gene decay. Our findings suggest early adaptation of Bpp to humans through modulation of the bvgAS regulon, and a rapid adaptation through the loss of PRN expression, representing a late evolutionary parallelism concomitant with acellular vaccination against whooping cough., The French National Reference Center for Whooping Cough and Other Bordetella Infections receives support from Institut Pasteur and Public Health France (Santé publique France, Saint Maurice, France). This work was supported financially by the French Government’s Investissement d’Avenir grants Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID) and INCEPTION (ANR-16-CONV-0005) and by the Spanish ‘Ministerio de Economía y Competitividad’ and ‘Instituto de Salud Carlos III’ [grant number FIS PI18/00703], and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas [grant number CB21/13/00054]). This work was also supported by the CDC’s Advanced Molecular Detection (AMD) programme.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986–2015

  • Mir Cros, Alba
  • Moreno Mingorance, Albert
  • Martin Gomez, M Teresa
  • Codina Grau, Gema
  • Cornejo Sánchez, Thais
  • Rajadell Guiu, Mireia
  • Rodrigo Gonzalo de Liria, Carlos
  • Pumarola Suñé, Tomàs
  • Fàbrega Santamaría, Anna
  • Gonzalez Lopez, Juan Jose
  • Campins Martí, Magda
MLVA; PFGE; Vacuna contra la tos ferina, MLVA; PFGE, Vacuna contra la tos ferina, MLVA; PFGE; Pertussis vaccine, Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). Additionally, allelic variants for the pertussis toxin and its promoter, pertactin, type 3 fimbriae and fimbrial serotyping were assessed to determine its antigenic drift. A shift was observed in the B. pertussis population as well as in its antigenic profile concurrently with the introduction of ACV in Barcelona. Four out of the five most prevalent PFGE profiles were replaced by new profiles following the ACV introduction. MLVA type 27 was the dominant genotype, and its frequency increased from 25% to 79.3% after WCV replacement. Antigen typing demonstrated the emergence of prn2, ptxP3, fim3-2 and a shift from the fimbriae 3 to the fimbriae 2 serotypes after the ACV introduction. Our findings support the presence of population and antigenic dynamic changes in B. pertussis likely driven by the introduction of ACV., This work was supported by the “Ministerio de Economía y Competitividad”, “Instituto de Salud Carlos III”, and cofinanced by the European Regional Development Fun (ERDF) “A Way to Achieve Europe” (Spanish Network for Research in Infectious Diseases [grant number RD16/0016/0003], “Fondo de Investigación Sanitaria [grant number FIS PI18/ 00703]). AMC is supported by the “Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya” [grant number 2018FI_B_00855].
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986-2015

  • Mir-Cros, Alba|||0000-0003-4827-9824
  • Moreno Mingorance, Albert|||0000-0002-3073-5046
  • Martin-Gomez, M. Teresa|||0000-0001-8119-8749
  • Codina, María Gema|||0000-0002-5313-5086
  • Cornejo-Sánchez, Thais|||0000-0002-1350-0413
  • Rajadell Guiu, Mireia
  • van Esso, Diego
  • Rodrigo Gonzalo de Líria, Carlos|||0000-0003-1140-2585
  • Campins Martí, Magda|||0000-0002-8841-6195
  • Jané i Checa, Mireia|||0000-0002-1302-6723
  • Pumarola Suñé, Tomàs|||0000-0002-5171-7461
  • Fàbrega-Santamaria, Anna|||0000-0002-3866-2291
  • González-López, Juanjo|||0000-0003-2419-5909
Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). Additionally, allelic variants for the pertussis toxin and its promoter, pertactin, type 3 fimbriae and fimbrial serotyping were assessed to determine its antigenic drift. A shift was observed in the B. pertussis population as well as in its antigenic profile concurrently with the introduction of ACV in Barcelona. Four out of the five most prevalent PFGE profiles were replaced by new profiles following the ACV introduction. MLVA type 27 was the dominant genotype, and its frequency increased from 25% to 79.3% after WCV replacement. Antigen typing demonstrated the emergence of prn2, ptxP3, fim3-2 and a shift from the fimbriae 3 to the fimbriae 2 serotypes after the ACV introduction. Our findings support the presence of population and antigenic dynamic changes in B. pertussis likely driven by the introduction of ACV.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis

  • Altadill, Tatiana
  • Dowdy, Tyrone M.
  • Gill, Kirandeep
  • Reques, Armando|||0000-0002-7197-9354
  • Menon, Smrithi S.
  • Moiola, Cristian Pablo|||0000-0001-7218-0184
  • López-Gil, Carlos|||0000-0001-6540-1225
  • Coll de la Rubia, Eva|||0000-0001-6709-7554
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Cabrera Díaz, Silvia|||0000-0002-3164-6686
  • Garcia, Angel
  • Reventos, Jaume
  • Byers, Stephen W.
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Cheema, Amrita K.
  • Colás Ortega, Eva|||0000-0003-0302-4828
Endometrial cancer (EC) remains the most common malignancy of the genital tract among women in developed countries. Although much research has been performed at genomic, transcriptomic and proteomic level, there is still a significant gap in the metabolomic studies of EC. In order to gain insights into altered metabolic pathways in the onset and progression of EC carcinogenesis, we used high resolution mass spectrometry to characterize the metabolomic and lipidomic profile of 39 human EC and 17 healthy endometrial tissue samples. Several pathways including lipids, Kynurenine pathway, endocannabinoids signaling pathway and the RNA editing pathway were found to be dysregulated in EC. The dysregulation of the RNA editing pathway was further investigated in an independent set of 183 human EC tissues and matched controls, using orthogonal approaches. We found that ADAR2 is overexpressed in EC and that the increase in expression positively correlates with the aggressiveness of the tumor. Furthermore, silencing of ADAR2 in three EC cell lines resulted in a decreased proliferation rate, increased apoptosis, and reduced migration capabilities in vitro. Taken together, our results suggest that ADAR2 functions as an oncogene in endometrial carcinogenesis and could be a potential target for improving EC treatment strategies.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

No innocent bystanders: pertussis vaccination and evolutionary parallelisms between Bordetella parapertussis and Bordetella pertussis

  • Bouchez, Valérie
  • Landier, Annie
  • Armatys, Nathalie
  • Guillot, Sophie
  • Moreno-Mingorance, Albert
  • Mir-Cros, Alba
  • Martin Gomez, M. Teresa
  • González-López, Juan José
Bordetella parapertussis; Phylogenetic diversity; Vaccine driven evolution, Bordetella parapertussis; Diversidad filogenética; Evolución impulsada por vacunas, Bordetella parapertussis; Diversitat filogenètica; Evolució impulsada per vacunes, Pathogens adapting to the human host and to vaccination-induced immunity may follow parallel evolutionary paths. Bordetella parapertussis (Bpp) contributes significantly to the burden of whooping cough (pertussis) and shares vaccine antigens with Bordetella pertussis (Bp); both pathogens are phylogenetically related and ecological competitors. Bp vaccine antigen-coding genes have accumulated variation, including pertactin (PRN) disruptions, after the introduction of acellular vaccines in the 1990s. We aimed to evaluate evolutionary parallelisms in Bpp, even though pertussis vaccines were designed against Bp. We sequenced 242 Bpp isolates collected in France, the USA and Spain between 1937 and 2019, spanning pre-vaccine and two vaccines eras. We investigated the temporal evolution of Bpp sublineages using a Bayesian approach based on whole-genome SNPs and performed comparative genomic analyses focusing on antigen and virulence gene loci. The most recent common ancestor of all sequenced Bpp isolates was estimated around the year 1877, making it one of the youngest human pathogens, and the Bpp evolutionary rate we estimated (2.12×10−7 substitutions per site per year) was remarkably similar to the one previously reported for Bp (2.24×10−7). PRN antigen deficiency in Bpp was driven by 18 disruptive mutations, including deletion prn:ΔG-1895 estimated to have occurred around 1998 and observed in 73.8 % (149/202) of post-2007 Bpp isolates. In addition, we detected two early (year ~1900) mutations in the bvgA-fhaB intergenic region, which controls multiple virulence factors including the filamentous haemagglutinin antigen. Gene clusters for pertussis toxin and fimbriae showed a surprising lack of gene decay. Our findings suggest early adaptation of Bpp to humans through modulation of the bvgAS regulon, and a rapid adaptation through the loss of PRN expression, representing a late evolutionary parallelism concomitant with acellular vaccination against whooping cough., The French National Reference Center for Whooping Cough and Other Bordetella Infections receives support from Institut Pasteur and Public Health France (Santé publique France, Saint Maurice, France). This work was supported financially by the French Government’s Investissement d’Avenir grants Laboratoire d’Excellence Integrative Biology of Emerging Infectious Diseases (ANR-10-LABX-62-IBEID) and INCEPTION (ANR-16-CONV-0005) and by the Spanish ‘Ministerio de Economía y Competitividad’ and ‘Instituto de Salud Carlos III’ [grant number FIS PI18/00703], and by the Centro de Investigación Biomédica en Red (CIBER de Enfermedades Infecciosas [grant number CB21/13/00054]). This work was also supported by the CDC’s Advanced Molecular Detection (AMD) programme.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Population dynamics and antigenic drift of Bordetella pertussis following whole cell vaccine replacement, Barcelona, Spain, 1986–2015

  • Mir Cros, Alba
  • Moreno Mingorance, Albert
  • Martin Gomez, M Teresa
  • Codina Grau, Gema
  • Cornejo Sánchez, Thais
  • Rajadell Guiu, Mireia
  • Rodrigo Gonzalo de Liria, Carlos
  • Pumarola Suñé, Tomàs
  • Fàbrega Santamaría, Anna
  • Gonzalez Lopez, Juan Jose
  • Campins Martí, Magda
MLVA; PFGE; Vacuna contra la tos ferina, MLVA; PFGE, Vacuna contra la tos ferina, MLVA; PFGE; Pertussis vaccine, Among the factors associated with the resurgence of whooping cough, special emphasis has been given to pathogen adaptation after the introduction of the acellular vaccine (ACV). To assess the impact of the vaccine transition strategy from whole-cell vaccine (WCV) to ACV on population dynamics of Bordetella pertussis in Barcelona (Spain), we studied 339 isolates collected from 1986 to 2015 by PFGE and multi-locus variable-number tandem repeat analysis (MLVA). Additionally, allelic variants for the pertussis toxin and its promoter, pertactin, type 3 fimbriae and fimbrial serotyping were assessed to determine its antigenic drift. A shift was observed in the B. pertussis population as well as in its antigenic profile concurrently with the introduction of ACV in Barcelona. Four out of the five most prevalent PFGE profiles were replaced by new profiles following the ACV introduction. MLVA type 27 was the dominant genotype, and its frequency increased from 25% to 79.3% after WCV replacement. Antigen typing demonstrated the emergence of prn2, ptxP3, fim3-2 and a shift from the fimbriae 3 to the fimbriae 2 serotypes after the ACV introduction. Our findings support the presence of population and antigenic dynamic changes in B. pertussis likely driven by the introduction of ACV., This work was supported by the “Ministerio de Economía y Competitividad”, “Instituto de Salud Carlos III”, and cofinanced by the European Regional Development Fun (ERDF) “A Way to Achieve Europe” (Spanish Network for Research in Infectious Diseases [grant number RD16/0016/0003], “Fondo de Investigación Sanitaria [grant number FIS PI18/ 00703]). AMC is supported by the “Agència de Gestió d'Ajuts Universitaris i de Recerca, Generalitat de Catalunya” [grant number 2018FI_B_00855].